Issue 18, 2015

Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold

Abstract

Hsp90 C-terminal ligands are potential new anti-cancer drugs alternative to the more studied N-terminal inhibitors. Here we report the identification of a new dihydropyrimidinone binding the C-terminus, which is not structurally related to other well-known natural and nature-inspired inhibitors of this second druggable Hsp90 site.

Graphical abstract: Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold

Supplementary files

Article information

Article type
Communication
Submitted
17 Dec 2014
Accepted
27 Jan 2015
First published
27 Jan 2015

Chem. Commun., 2015,51, 3850-3853

Author version available

Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold

M. Strocchia, S. Terracciano, M. G. Chini, A. Vassallo, M. C. Vaccaro, F. Dal Piaz, A. Leone, R. Riccio, I. Bruno and G. Bifulco, Chem. Commun., 2015, 51, 3850 DOI: 10.1039/C4CC10074C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements